Canada: Common Sense Guidance Offers Clarity To Issuers: CSA Confirms Disclosure-Based Rules For Issuers Involved In U.S. Marijuana-Related Activities

The Canadian Securities Administrators (the "CSA") recently published CSA Staff Notice 51-352 Issuers with U.S. Marijuana-Related Activities (the "Staff Notice") detailing disclosure expectations for issuers1 involved in marijuana-related practices or activities in U.S. states that have legalized such activities ("U.S. Marijuana Issuers").2 These activities include the cultivation, possession, and distribution of marijuana ("marijuana-related activities").3 Despite the presence of licensing and regulation of marijuana in various U.S. states, marijuana-related activities remain illegal under U.S. federal law.4 The Staff Notice provides guidance to U.S. Marijuana Issuers on how they can satisfy the CSA's disclosure expectations. The expectations outlined in the Staff Notice conform with the disclosure-based system adopted by securities regulatory authorities in Canada. The expectations effectively outline that U.S. Marijuana Issuers are required to provide disclosure to the market to allow investors to, among other things, make decisions on the basis of all material facts, risks, and uncertainties related to their business.5 The Staff Notice outlines the disclosure requirements for issuers on the basis of the type of activities being undertaken, and the consequences of inadequate disclosure.

Disclosure Requirements for All Issuers

U.S. Marijuana Issuers must describe the nature of the issuer's involvement in the U.S. marijuana industry and include the disclosure indicated for the direct, indirect, or ancillary industry involvement types, each of which is discussed in further detail below. Additionally, U.S. Marijuana Issuers are required to provide disclosure that marijuana remains illegal under U.S. federal law and that the forbearance-based enforcement approach is subject to change,6 and also discuss the resultant risks, including the risk of adverse enforcement action. The issuer is further required to state whether and, if so, how the issuer's U.S. marijuana-related activities are conducted in a manner consistent with any U.S. federal enforcement priorities, discuss the issuer's ability to access both public and private capital, and indicate what financing options are available to support continuing operations.7

Disclosure Requirements for Issuers Involved in Cultivation or Distribution

Issuers with direct involvement in the cultivation or distribution of marijuana, either through their own engagement in those activities or through that of a subsidiary, must outline the regulations for the U.S. states in which the issuer operates, confirm how the issuer complies with applicable licensing requirements and the regulatory framework enacted by the applicable U.S. state, discuss the issuer's program for monitoring compliance with U.S. state law on an ongoing basis, outline internal compliance procedures, and disclose any material non-compliance as well as material citations or notices of violation.

Issuers with indirect involvement in the cultivation or distribution, such as issuers who have a non-controlling investment in an entity that is involved in cultivation or distribution of marijuana, must outline the regulations for U.S. states in which the issuer's investee operates, and provide reasonable assurance that the investee's business is in compliance with applicable licensing requirements and the regulatory framework enacted by the applicable U.S. state.8

Disclosure Requirements for Issuers with Ancillary Involvement

Issuers with material ancillary involvement in the marijuana industry, such as those who provide goods or services (including financing, branding, or leasing) to third parties that are directly involved in the U.S. marijuana industry, must provide reasonable assurance, either through positive or negative statements, that the customer or investee's business is in compliance with the licensing requirements and the regulatory framework enacted by the applicable U.S. state.9

Consequences of Non-Compliance

U.S. Marijuana Issuers who do not provide appropriate disclosure may be subject to regulatory action, such as receipt refusal in the context of prospectus offerings and referrals for appropriate enforcement action. In addition, with respect to continuous disclosure obligations, U.S. Marijuana Issuers may be subject to requests for restatements of non-compliant filings. In our view, it is likely that the securities regulators in Canada will implement periodic continuous disclosure reviews for U.S. Marijuana Issuers much like the review process for industries such as mining. If a U.S. Marijuana Issuer does not comply with the guidance in the Staff Notice then one tool the applicable securities regulator will likely use is to require the issuer to retract and restate the applicable disclosure. Accordingly, it would be prudent for U.S. Marijuana Issuers to retain professional advisors who have knowledge of this evolving industry and who are able to craft continuous disclosure that conforms to the guidance provided in the Staff Notice.

The CSA staff further note that if the U.S. federal government changes its forbearance-based enforcement approach, then the CSA will re-examine its views with regards to U.S. Marijuana Issuers.10

Responses to the Staff Notice by Securities Exchanges in Canada

Concurrent with the release of the Staff Notice, the Toronto Stock Exchange (the "TSX"), the TSX Venture Exchange (the "TSX-V"), and the Canadian Securities Exchange (the "CSE") each released notices regarding their respective policies concerning U.S. Marijuana Issuers. The responses from the stock exchanges remain consistent with their respective historical approaches to U.S. Marijuana Issuers.

In an October 16, 2017 news release the CSE applauded the Staff Notice and the clarity that it has provided U.S. Marijuana Issuers. Further, the CSE indicated that it remains committed to listing and providing services to U.S. Marijuana Issuers.11 Richard Carleton, CEO of the CSE, is quoted as saying that the Staff Notice "...provides significant comfort to these issuers that their Canadian listings will remain in good standing as long as they provide the disclosure that is rightly required by regulators."12 This approach remains consistent with the CSE position, as more particularly outlined in the CSE's news release of August 4, 2017,13 indicating that the CSE supports the listing of issuers involved in the U.S. marijuana industry provided that appropriate risk disclosure is made, and that such issuers operate in accordance with the applicable laws at the state level.

The TSX and the TSX-V approaches are similar to each other (not surprisingly as they have common ownership), but the polar opposite of the approach taken by the CSE.14 The TSX and the TSX-V have each indicated that they consider marijuana-related activities in the U.S. to be a violation of their respective listing requirements due to the federal prohibition on marijuana in the U.S. For issuers that are U.S. Marijuana Issuers seeking a listing on the TSX or TSX-V, the current guidance indicates that listing approval would not be accepted. For currently listed issuers who may seek to transition into the U.S. marijuana industry or buttress existing businesses with such activities in the U.S., their continued listing status would at a minimum be subject to a continued listing review and possibly be in jeopardy. Finally, for those issuers that are currently listed on the TSX or TSX-V and are U.S. Marijuana Issuers, such issuers would be subject to a continued listing review and it appears that the stock exchange listing could be in jeopardy unless and until such issuer divested the offending assets and/or ceased the applicable marijuana-related activities. However, it is important to note that the TSX and TSX-V specifically stated in their notices that they will continue to monitor legal developments in the U.S.


The expectations of the CSA, and the positions confirmed by each of the CSE, the TSX, and the TSX-V, serve to provide clarity regarding the obligations and restrictions of U.S. Marijuana Issuers, and those issuers seeking to enter the marijuana space in the U.S. The disclosure expectations that the CSA has imposed are a reflection of the Canadian securities regime as being disclosure-based, and the Staff Notice can be considered a clarification of the type of disclosure that would be required under applicable securities laws. The responses from each of the stock exchanges15 also serve to reinforce that they continue to hold the same positions: the TSX and TSX-V will continue to view marijuana-related activities by issuers listed on their respective exchanges as non-compliant with their exchange rules, and the CSE will continue to allow the listing of U.S. Marijuana Issuers, while all parties commit to monitor developments in the area as they may arise. The Staff Notice provides greater clarity and should be a well-received development to U.S. Marijuana Issuers and issuers who may seek to incorporate marijuana-related activities into their businesses.


[1] A reference to "issuer" means a "reporting issuer" as such term is defined under applicable Canadian securities law.

[2] In this bulletin we use the term "marijuana" rather than the more precise term "cannabis" to track the language in the Staff Notice.

[3] CSA Staff Notice 51-352, section I.

[4]In the U.S. there is a conflict between state and federal law related to marijuana. As the Staff Notice indicates, certain U.S. states permit marijuana use and sale within a regulatory framework notwithstanding that marijuana continues to be listed as a controlled substances under U.S. federal law and accordingly federally illegal.

[5] CSA Staff Notice 51-352, section II.

[6] In a memorandum dated August 29, 2013 addressed to "All United States Attorneys" from James M. Cole then Deputy Attorney General of the United States, (the "Cole Memorandum"), the U.S. Department of Justice stated that it is not an efficient use of limited resources to direct federal law enforcement agencies to prosecute those that are abiding by state laws allowing use and distribution of medical marijuana. It remains uncertain as to whether prosecutorial priorities will shift in the future, however at present the U.S. Department of Justice is not prioritizing prosecution if the requirements of the Cole Memorandum are met.

[7] Supra note 4.

[8] Ibid.

[9] Ibid.

[10] Ibid.

[11]Canadian Securities Exchange (CSE), News Release, "CSE Comments on CSA Staff Notice Regarding Issuers with U.S. Cannabis-Related Activities" (16 October 2017).

[12] Ibid.

[13] CSE, News Release, "CSE Confirms Position on U.S. Cannabis Listings" (4 August 2017).

[14] Toronto Stock Exchange (TSX), Staff Notice to Applicants, Listed Issuers, Securities Lawyers and Participating Organizations, 2017-0009 (16 October 2017); and TSX Venture Exchange, Notice to Issuers, "Business Activities Related to Marijuana in the United States" (16 October 2017).

[15] Ibid.

The foregoing provides only an overview and does not constitute legal advice. Readers are cautioned against making any decisions based on this material alone. Rather, specific legal advice should be obtained.

© McMillan LLP 2017

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions